UiPath, Inc. (NYSE:PATH – Get Free Report) saw unusually large options trading on Thursday. Stock traders purchased 110,442 call options on the stock. This represents an increase of approximately 78% compared to the average daily volume of 62,173 call options.
Trending Headlines about UiPath
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: UiPath posted first-quarter EPS of $0.15, matching Wall Street estimates, while revenue came in at $418.4 million versus consensus of about $397.5 million, showing a modest top-line beat. UiPath Reports First Quarter Fiscal 2027 Financial Results
- Positive Sentiment: The company said annual recurring revenue rose 12% year over year to $1.901 billion, suggesting continued customer adoption and healthy underlying demand for its automation and agentic AI products. UiPath Reports First Quarter Fiscal 2027 Financial Results
- Neutral Sentiment: Management’s next-quarter revenue outlook of $395 million to $400 million is close to analyst expectations, and full-year revenue guidance is also broadly in line, which limits upside from guidance alone. UiPath Reports First Quarter Fiscal 2027 Financial Results
- Neutral Sentiment: UiPath also expanded its partnership with Deloitte to integrate Test Cloud into Deloitte’s Ascend platform, which could support longer-term enterprise adoption of its AI-driven testing tools. UiPath Deloitte Deal Highlights Agentic AI Testing And Adoption Potential
- Negative Sentiment: Some commentary suggests UiPath still faces slower growth expectations versus higher-momentum AI software peers, which may cap enthusiasm after the report. Palantir vs. UiPath: Which AI-First Software Stock is a Buy?
UiPath Stock Performance
NYSE PATH opened at $11.60 on Friday. UiPath has a twelve month low of $9.20 and a twelve month high of $19.84. The stock has a market capitalization of $6.08 billion, a PE ratio of 22.31, a P/E/G ratio of 1.83 and a beta of 0.91. The stock has a 50-day simple moving average of $10.74 and a 200 day simple moving average of $12.91.
Hedge Funds Weigh In On UiPath
Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in UiPath by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 49,114,941 shares of the company’s stock valued at $804,994,000 after acquiring an additional 1,219,057 shares in the last quarter. State Street Corp raised its holdings in UiPath by 66.4% in the 4th quarter. State Street Corp now owns 13,004,786 shares of the company’s stock valued at $213,148,000 after acquiring an additional 5,189,438 shares in the last quarter. AQR Capital Management LLC raised its holdings in UiPath by 76.0% in the 2nd quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company’s stock valued at $145,732,000 after acquiring an additional 4,926,341 shares in the last quarter. Bank of America Corp DE raised its holdings in UiPath by 13.2% in the 1st quarter. Bank of America Corp DE now owns 10,046,699 shares of the company’s stock valued at $111,518,000 after acquiring an additional 1,170,285 shares in the last quarter. Finally, Morgan Stanley raised its holdings in UiPath by 54.0% in the 4th quarter. Morgan Stanley now owns 9,310,304 shares of the company’s stock valued at $152,596,000 after acquiring an additional 3,262,930 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on PATH shares. Mizuho decreased their price target on UiPath from $15.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, March 12th. Needham & Company LLC raised UiPath from a “hold” rating to a “buy” rating and set a $15.00 price objective for the company in a research report on Thursday, March 12th. Wells Fargo & Company cut their price objective on UiPath from $14.00 to $13.00 and set an “equal weight” rating for the company in a research report on Thursday, March 12th. Wall Street Zen cut UiPath from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 28th. Finally, Bank of America cut their price objective on UiPath from $14.00 to $12.00 and set an “underperform” rating for the company in a research report on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $14.07.
Check Out Our Latest Analysis on PATH
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Featured Stories
- Five stocks we like better than UiPath
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
